| Literature DB >> 25860949 |
Alejandro Madrid1, Venera Cardile2, César González3, Ivan Montenegro4, Joan Villena5, Silvia Caggia6, Adriana Graziano7, Alessandra Russo8.
Abstract
With the aim of identifying novel agents with antigrowth and pro-apoptotic activity on melanoma cancer, the present study was undertaken to investigate the biological activity of the resinous exudate of aerial parts from Psoralea glandulosa, and its active components (bakuchiol (1), 3-hydroxy-bakuchiol (2) and 12-hydroxy-iso-bakuchiol (3)) against melanoma cells (A2058). In addition, the effect in cancer cells of bakuchiol acetate (4), a semi-synthetic derivative of bakuchiol, was examined. The results obtained show that the resinous exudate inhibited the growth of cancer cells with IC50 value of 10.5 μg/mL after 48 h of treatment, while, for pure compounds, the most active was the semi-synthetic compound 4. Our data also demonstrate that resin is able to induce apoptotic cell death, which could be related to an overall action of the meroterpenes present. In addition, our data seem to indicate that the apoptosis correlated to the tested products appears, at least in part, to be associated with an increase of reactive oxygen species (ROS) production. In summary, our study provides the first evidence that P. glandulosa may be considered a source of useful molecules in the development of analogues with more potent efficacy against melanoma cells.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25860949 PMCID: PMC4425060 DOI: 10.3390/ijms16047944
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Chemical structures of natural (1–3) and semi-synthetic (4) meroterpenes.
Figure 2(A) Viabilities of A2058 melanoma cells and (B) Viabilities of fibroblast cells following treatment with resinous exudate for 48 h were measured as described in “Experimental Section”. Data are expressed as a percentage of the number of viable cells observed with the control, and each column represents the mean ± SD of three experiments, performed in quadruplicate. Significantly different from the control value: *p < 0.001.
Cell viability and Lactate dehydrogenase (LDH) release of compounds 1–4 tested against A2058 human melanoma cell line.
| Sample | IC50 a (µM) | % LDH b |
|---|---|---|
| 1 | 29.3 ± 0.4 | 5.9 ± 0.6 |
| 2 | 32.3 ± 0.6 | 6.1 ± 0.5 |
| 3 | 35.1 ± 0.5 | 6.9 ± 0.4 |
| 4 | 16.9 ± 0.4 | 7.3 ± 0.4 |
| Doxorubicin | 0.20 ± 0.01 | - |
| Negative Control | 100 | 6.5 ± 0.9 |
a IC50: value represents the concentration that inhibited cell vitality by 50%. Each value represents the mean ± SD of three experiments, performed in quadruplicate; b % LDH: value expressed as percentage of LDH released into the cell medium with respect to total LDH, in A2058 cells untreated and treated for 48 h with compounds 1–4 at 40 µM concentration. Negative control: Cultures received DMSO alone.
Lactate dehydrogenase (LDH) release in A2058 cells treated with different concentrations of resinous exudate of P. glandulosa.
| Sample | Treatment | %LDH a |
|---|---|---|
| Resinous exudate | 3.12 μg/mL | 7.5 ± 0.6 |
| 6.25 μg/mL | 9.7 ± 0.5 | |
| 12.5 μg/mL | 8.9 ± 0.7 | |
| 25 μg/mL | 8.8 ± 0.6 | |
| H2O2 | 1 μM | 5.8± 0.7 |
| 1000 μM | 71.3± 1.7 * | |
| Negative control | 0.25% | 7.5 ± 0.7 |
a The values are the mean ± SD of three experiments performed in quadruplicate; * Significant vs. control untreated cells (p < 0.001) Stock solution of resinous exudate was prepared in DMSO and the final concentration of this solvent was kept constant at 0.25%. Negative control: Cultures received DMSO alone.
Figure 3Comet assay in A2058 cancer cells untreated and treated at different concentrations for 48 h with (A,B) resinous exudates; with (C,D) compounds 1–4 were measured as described in “Materials and Methods”. The values are the mean ± SD of three experiments performed in quadruplicate. Significantly different from the control value: *p < 0.001.
Caspase-3 activity in A2058 cancer cells untreated and treated with resinous exudate and compounds 1–4 at different concentrations for 48 h.
| Sample | Treatment | OD405 nm/mg Protein |
|---|---|---|
| Resinous exudate | 3.12 μg/mL | 0.41 ± 0.03 * |
| 6.25 μg/mL | 0.55 ± 0.06 * | |
| 12.5 μg/mL | 0.84 ± 0.05 * | |
| Compound | 5 μM | 0.45 ± 0.05 * |
| 10 μM | 0.63 ± 0.04 * | |
| 20 μM | 0.89 ± 0.09 * | |
| Compound | 5 μM | 0.38 ± 0.06 * |
| 10 μM | 0.55 ± 0.04 * | |
| 20 μM | 0.77 ± 0.09 * | |
| Compound | 5 μM | 0.39 ± 0.04 * |
| 10 μM | 0.62 ± 0.04 * | |
| 20 μM | 0.81 ± 0.06 * | |
| Compound | 5 μM | 0.65 ± 0.03 * |
| 10 μM | 0.73 ± 0.04 * | |
| 20 μM | 0.97 ± 0.06 * | |
| H2O2 | 1 μM | 0.89 ± 0.09 * |
| Negative control | 0.25% | 0.27 ± 0.06 |
The values are the mean ± SD of three experiments performed in quadruplicate. * Significant vs. control untreated cells (p < 0.001). Hydrogen peroxide (1 μM) was used as a positive control. Stock solution of extract was prepared in DMSO and the final concentration of this solvent was kept constant at 0.25%.
Figure 4Levels of Bcl-2, Bax and p53 proteins in A2058 cells untreated and for 48 h were measured as described in “Materials and Methods” treated with (A1) resinous exudate and (B1) compounds 1–4; Bax/Bcl2 ratio treated with (A2) resinous exudates and (B2) compounds 1–4. Values are expressed as arbitrary densitometric units (A.D.U.) corresponding to signal intensity present on the autoradiography of western blots. Representative blots are reported above each graph. Each value represents the mean ± SD of three experiments, performed in quadruplicate. * Significant vs. control untreated cells (p < 0.001).
Figure 5Reactive oxygen species (ROS) determination were measured as described in “Experimental Section”, in A2058 cells untreated and treated for 48 h with resinous exudate (A) and pure compounds 1–4 (B) at different concentrations. The values are the mean ± SD of three experiments performed in quadruplicate. * Significant vs. control untreated cells (p < 0.001).